Evidence map›Paper›PMID 30238152›Full record

ArticleMycorrhiza2018

Mycelium of Terfezia claveryi as inoculum source to produce desert truffle mycorrhizal plants.

Francisco Arenas, Alfonso Navarro-Ródenas, Daniel Chávez, Almudena Gutiérrez, Manuela Pérez-Gilabert, Asunción Morte

Abstract read
PubMed Publisher
In one paragraph

Article in Mycorrhiza, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Francisco ArenasDepartamento de Biología Vegetal, Facultad de Biología, Universidad de Murcia, Campus de Espinardo, 30100, Murcia, Spain.
Alfonso Navarro-RódenasDepartamento de Biología Vegetal, Facultad de Biología, Universidad de Murcia, Campus de Espinardo, 30100, Murcia, Spain.
Daniel ChávezDepartamento de Ciencias y Tecnología Vegetal, Campus Los Ángeles, Universidad de Concepción, Escuela de Ciencias y Tecnologías, Los Angeles, Chile.
Almudena GutiérrezDepartamento de Biología Vegetal, Facultad de Biología, Universidad de Murcia, Campus de Espinardo, 30100, Murcia, Spain.
Manuela Pérez-GilabertDepartamento de Bioquímica y Biología Molecular A, Facultad de Veterinaria, Universidad de Murcia, Campues de Espinardo, 30100, Murcia, Spain.
Asunción MorteDepartamento de Biología Vegetal, Facultad de Biología, Universidad de Murcia, Campus de Espinardo, 30100, Murcia, Spain. amorte@um.es.ORCID http://orcid.org/0000-0002-6426-0202

Funding

Fundación Séneca 19484/PI/14Ministerio de Economía y Competitividad CGL2016-78946-R
6 · The paper itself

Abstract

Terfezia claveryi Chatin was the first desert truffle species to be cultivated, the mycorrhizal plants being successfully produced by using both desert truffle spores and mycelia. However, it is more advisable to use mycelium than spores whenever possible and profitable. Given the low yields of mycelia obtained using traditional culture methods of this truffle, the medium composition was modified in an attempt to determine its nutritional requirements. For this, an assay involving response surface methodology was performed using Box-Behnken design to find the optimal parameters for the high production of mycelial biomass. The best results were obtained with glucose as carbon source, buffering the pH at 5 during culture, adding a pool of vitamins, and adjusting the optimal concentrations of carbon and nitrogen sources of the MMN medium. Biomass production increased from 0.3 to 3 g L

Indexed as

AscomycotaCistaceaeMyceliumMycorrhizaePlant RootsBox-Behnken designDesert truffleMycelial biomassResponse surface methodologyTerfezia claveryi

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.